Saturday, July 20, 2024 11:50:09 AM
Don't show me a BIEL press release or a marketing piece from their website. Show me the clinical evidence.
Because that is what the CMS requires for the NOPAIN Act.
As of this writing, the CMS has approved only one device for the NOPAIN Act. If BIEL has clinical evidence, why is the ActiPatch not included? Does BIEL have this evidence but hasn't bothered showing it to the CMS yet? What is more important than NOPAIN Act inclusion? It should be BIEL's number one priority.
Their number two priority should be informing their shareholders what they are doing to get the device approved by the CMS for the NOPAIN Act.
BTW in addition to explaining what a "CHALLANGE" is, perhaps you could define these words?
"PROVOCOTURES"
"acceptations"
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM